Lexicon Pharmaceuticals LXRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's current ratio?
- Lexicon Pharmaceuticals (LXRX) reported current ratio of 18.8× in Q1 2026.
- How has Lexicon Pharmaceuticals's current ratio changed year-over-year?
- Lexicon Pharmaceuticals's current ratio increased by 746.4% year-over-year, from 2.2× to 18.8×.
- What is the long-term trend for Lexicon Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's current ratio has grown at a 7.7% compound annual growth rate (CAGR), from 3.4× to 4.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.